These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 3553166

  • 1. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
    Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A.
    J Clin Psychiatry; 1987 May; 48 Suppl():9-15. PubMed ID: 3553166
    [Abstract] [Full Text] [Related]

  • 2. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP, Wirshing WC.
    J Clin Psychiatry; 2001 May; 62 Suppl 21():19-22. PubMed ID: 11584983
    [Abstract] [Full Text] [Related]

  • 3. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
    Gleason RP, Schneider LS.
    J Clin Psychiatry; 1990 Mar; 51(3):115-8. PubMed ID: 1968457
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Behavioral pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): Spanish validation].
    Boada M, Tárraga L, Modinos G, Diego S, Reisberg B.
    Neurologia; 2006 Oct; 21(1):19-25. PubMed ID: 16525922
    [Abstract] [Full Text] [Related]

  • 8. Behavioral outcomes in clinical trials for Alzheimer disease.
    Ferris SH, Mackell JA.
    Alzheimer Dis Assoc Disord; 1997 Oct; 11 Suppl 4():S10-5. PubMed ID: 9339267
    [Abstract] [Full Text] [Related]

  • 9. [In Alzheimer's disease, the clinical expression of behavioral and psychological signs and symptoms is early and specific of neuropathological stages].
    Michel BF, Luciani V, Geda YE, Sambuchi N, Paban V, Azorin JM.
    Encephale; 2010 Sep; 36(4):314-25. PubMed ID: 20850603
    [Abstract] [Full Text] [Related]

  • 10. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
    Fujikawa T, Takahashi T, Kinoshita A, Kajiyama H, Kurata A, Yamashita H, Yamawaki S.
    Neuropsychobiology; 2004 Sep; 49(4):201-4. PubMed ID: 15118358
    [Abstract] [Full Text] [Related]

  • 11. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG, Sultzer DL, Wheatley MV.
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [Abstract] [Full Text] [Related]

  • 12. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia.
    Skjerve A, Holsten F, Aarsland D, Bjorvatn B, Nygaard HA, Johansen IM.
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):343-7. PubMed ID: 15298644
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effects of perospirone on aggressive behavior associated with dementia.
    Sato S, Mizukami K, Moro K, Tanaka Y, Asada T.
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
    [Abstract] [Full Text] [Related]

  • 14. [The clinical picture and stability of non-cognitive symptoms in patients with Alzheimer's disease].
    Haupt M, Jänner M, Stierstorfer A, Kretschmar C.
    Fortschr Neurol Psychiatr; 1998 May; 66(5):233-40. PubMed ID: 9653639
    [Abstract] [Full Text] [Related]

  • 15. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T, Meguro K, Akanuma K, Meguro M, Lee E, Kasuya M, Ishii H, Mori E.
    J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
    [Abstract] [Full Text] [Related]

  • 16. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.
    Lemke MR.
    J Clin Psychiatry; 1995 Aug; 56(8):354-7. PubMed ID: 7635851
    [Abstract] [Full Text] [Related]

  • 17. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
    Shimabukuro J, Awata S, Matsuoka H.
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
    [Abstract] [Full Text] [Related]

  • 18. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
    Steele C, Lucas MJ, Tune L.
    J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers.
    Finkel SI.
    J Clin Psychiatry; 2001 Jun; 62 Suppl 21():3-6. PubMed ID: 11584987
    [Abstract] [Full Text] [Related]

  • 20. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.
    Encephale; 2003 Jun; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.